In 2021, Kishimoto et al., in a double-blind, placebo-controlled clinical trial, evaluated the anti-inflammatory effects of curcuRouge for 4 weeks on systemic inflammation in adults over 60 years of age in Japan [62]
For most healthy adults with a qualified provider, yes
However, given the associated risks of cardiovascular disease and various cancers, the benefits of these medications, such as better glycemic control, weight loss and improvement in cardiometabolic risk factors as well as other obesity complications, appear to outweigh the risks for most adults with obesity [143, 153]
Personalized Programs for Maximum Efficacy Personalization is Key: Understanding that each body is different, our pharmacists work with you to customize a weight loss plan that fits your unique needs, incorporating GLP-1 medications where suitable
G.RouwsL
Both receptors are critical to controlling metabolic functions